NCT05126979View on ClinicalTrials.gov

The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 9, 2016

Primary Completion Date

April 25, 2016

Study Completion Date

May 13, 2016

Conditions

Influenza

Interventions

BIOLOGICAL

Inactivated Split Influenza Vaccine

BIOLOGICAL

Placebo

Trial Locations (1)

Unknown

Perm State Medical University named after academician E.A. Wagner, Perm

All Listed Sponsors

lead

St. Petersburg Research Institute of Vaccines and Sera

OTHER_GOV

NCT05126979 - The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years | Biotech Hunter | Biotech Hunter